REAL-WORLD BORTEZOMIB USAGE PATTERNS AMONG PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

被引:0
|
作者
Calkins, G. [1 ]
Kohansimeh, J. [1 ]
Krishna, A. [2 ]
Green, R. J. [1 ]
Curtis, M. [1 ]
Lindberg, F. P. [1 ]
Jaskiw, A. [1 ]
Larrabee, K. [1 ]
Terry, M. [1 ]
Feinstein, R. N. [1 ]
Plotkin, L. [1 ]
Palladino, M. L. [1 ]
Nicacio, L. Viana [1 ]
机构
[1] Flatiron Hlth, New York, NY USA
[2] Novartis Pharmaceut, E Hanover, NJ USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PB1881
引用
收藏
页码:742 / 742
页数:1
相关论文
共 50 条
  • [1] Bortezomib therapy in a real-world setting in patients with relapsed or refractory multiple myeloma
    Huang, Shang-Yi
    Chen, Tsai-Yun
    Kuo, Ching-Yuan
    Chen, Yeu-Chin
    Lin, Sheng-Fung
    Chang, Ming-Chih
    Lv, Xinzhu
    Yang, Betty
    Chang, Cheng-Shyong
    [J]. ONCOLOGY REVIEWS, 2019, 13 (01) : 15 - 22
  • [2] Real-World Practice Patterns with Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma
    Harvey, R. Donald
    Cong, Ze
    Werther, Winifred
    Lethen, Jan L.
    Lonial, Sagar
    [J]. BLOOD, 2014, 124 (21)
  • [3] Bortezomib retreatment for relapsed and refractory multiple myeloma in real-world clinical practice
    Hulin, Cyrille
    de la Rubia, Javier
    Dimopoulos, Meletios A.
    Terpos, Evangelos
    Katodritou, Eirini
    Hungria, Vania
    De Samblanx, Hadewijch
    Stoppa, Anne-Marie
    Aagesen, Jesper
    Sargin, Deniz
    Sioni, Anastasia
    Belch, Andrew
    Diels, Joris
    Olie, Robert A.
    Robinson, Don, Jr.
    Potamianou, Anna
    van de Velde, Helgi
    Delforge, Michel
    [J]. HEALTH SCIENCE REPORTS, 2019, 2 (01)
  • [4] Current Real-World Treatment Patterns and Outcomes in Patients with Relapsed/Refractory Multiple Myeloma
    Willson, Jenny
    Bruno, Amanda
    Opalinska, Joanna
    Nelson, Jeannene
    Lunacsek, Orsolya
    Stafkey-Mailey, Dana
    Willey, Joanne
    [J]. BLOOD, 2018, 132
  • [5] Real-World Outcomes with Panobinostat in Patients with Relapsed/Refractory Multiple Myeloma
    Biran, Noa
    Vesole, David H.
    Zhang, Shijia
    Richter, Joshua R.
    Kuo, Yen-Hong
    Schmidt, Linda
    McBride, Laura
    Anand, Palka
    Ivanovski, Kristin
    Pierre, Amy
    Kumka, Susan
    Cuccurullo, Carmela
    Siegel, David S.
    [J]. BLOOD, 2016, 128 (22)
  • [6] Recent real-world treatment patterns and outcomes in US patients with relapsed/refractory multiple myeloma
    Bruno, Amanda S.
    Willson, Jenny L.
    Opalinska, Joanna M.
    Nelson, Jeanenne J.
    Lunacsek, Orsolya E.
    Stafkey-Mailey, Dana R.
    Willey, Joanne P.
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (09) : 1017 - 1025
  • [7] Current real-world treatment patterns and outcomes in patients with relapsed/refractory multiple myeloma.
    Willson, Jenny
    Bruno, Amanda
    Opalinska, Joanna
    Nelson, Jeanenne Joy
    Lunacsek, Orsolya
    Stafkey-Mailey, Dana
    Willey, Joanne P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] Real-world effectiveness and safety of daratumumab, bortezomib, and dexamethasone in relapsed/refractory multiple myeloma in Slovakia
    Harvanova, L'ubica
    Stulajterova, Viera
    Guman, Tomas
    Ladicka, Miriam
    Hlebaskova, Monika
    Chudej, Juraj
    Simek, Miroslav
    Stecova, Natalia
    Flochova, Emilia
    Kubala, Jan
    Simancikova, Iveta
    Drgona, L'ubos
    Vranovsky, Andrej
    Wild, Alexander
    Mistrik, Martin
    Batorova, Angelika
    [J]. NEOPLASMA, 2021, 68 (03) : 626 - 630
  • [9] Bortezomib-based therapy for relapsed/refractory multiple myeloma in real-world medical practice
    Terpos, Evangelos
    Katodritou, Eirini
    de la Rubia, Javier
    Hungria, Vania
    Hulin, Cyrille
    Roussou, Maria
    Delforge, Michel
    Bries, Greet
    Stoppa, Anne-Marie
    Aagesen, Jesper
    Sargin, Deniz
    Belch, Andrew
    Ahlberg, Lucia
    Diels, Joris
    Olie, Robert A.
    Robinson, Don, Jr.
    Spencer, Mike
    Potamianou, Anna
    van de Velde, Helgi
    Dimopoulos, Meletios A.
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (04) : 556 - 565
  • [10] Real-World Treatment Patterns, Health Care Utilization, and Costs Among Relapsed/Refractory Multiple Myeloma (rrMM) Patients
    Shao, Changxia
    Monberg, Matthew
    Cao, Xiting
    Zhou, Wei
    Zhong, Yichen
    Marinello, Patricia
    [J]. BLOOD, 2016, 128 (22)